Notify your doctor right away if you have Fabry disease and become pregnant.

You may be eligible to participate in the Fabry Pregnancy Registry.

What Your Participation Means

Your participation in this registry will help Amicus Therapeutics, Inc. learn valuable health information regarding pregnancies of women who have Fabry disease. The health information learned from this registry will be shared with the U.S. Food and Drug Administration (FDA) and other regulatory agencies and may help other women who have Fabry disease to better understand the impact the disease and its treatments might have on pregnancies and child development.

Information submitted to the registry will be maintained as confidential in accordance with applicable national privacy regulations and other state and local laws related to medical information.

Are You Eligible?

This voluntary registry will enroll women with Fabry disease, who are/were pregnant or who are/were breastfeeding within the first year of their child's birth. Women currently receiving treatment, and women who previously or never received treatment for their Fabry disease may enroll in the registry.

This is a global registry and you are eligible to participate in either of the two scenarios outlined below:

Note: Your information will not be shared for any other purpose other than for the Pregnancy Coordinating Center to contact you. Please refer to Privacy Policy and Terms of Use within this website.

Information submitted to the registry will be maintained as confidential in accordance with applicable national privacy regulations and other state and local laws related to medical information.

To report Suspected Adverse Reactions, contact Amicus Therapeutics at 1-877-4AMICUS or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.